I think they will be more willing to partner Prurisol than Brilacidin or Kevetrin. It should be relatively easy to determine the value of the drug and with the (505b2) the side effects profile should be fairly predictable as well. If its effective it should be very attractive to a potential partner.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links